Long‐term exposure to monoclonal anti‐TNF is associated with an increased risk of lymphoma in BAFF‐transgenic mice

The impact of treatment on the risk of lymphoma in patients with rheumatoid arthritis (RA) is unclear. Here, we aimed to assess if the risk of lymphoma differs according to the type of tumor necrosis factor inhibitor (TNFi), comparing monoclonal anti‐TNF antibodies to the soluble TNF receptor. We us...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Exp Immunol
Prif Awduron: Nocturne, Gaetane, Ly, Bineta, Paoletti, Audrey, Pascaud, Juliette, Seror, Raphaele, Nicco, Carole, Mackay, Fabienne, Vincent, F.B., Lazure, Thierry, Ferlicot, Sophie, Stimmer, Lev, Pascal, Quentin, Roulland, Sandrine, Krzysiek, Roman, Hacein‐Bey, Salima, Batteux, Frederic, Mariette, Xavier
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2021
Pynciau:
ORIGINAL ARTICLES
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274188/
https://ncbi.nlm.nih.gov/pubmed/33864242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13602
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg